Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Cepheid Inc (CPHD)

Cepheid Inc (CPHD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Cepheid Inc 904 CARIBBEAN DRIVE SUNNYVALE CA 94089

www.cepheid.com P: 408-541-4191

Description:

Cepheid, Inc. develops, manufactures and markets microfluidic systems that integrate, automate and accelerate biological testing. Their systems are miniaturized instruments that analyze complex biological samples in a disposable cartridge by combining molecular biology with microfluidic technology that processes small quantities of liquid, typically using components fabricated with computer chip technology. These systems rapidly perform all of the steps required to analyze complex biological samples.

Key Statistics

Overview:

Market Capitalization, $K 3,880,330
Shares Outstanding, K 72,890
Annual Sales, $ 538,580 K
Annual Net Income, $ -48,530 K
Last Quarter Sales, $ 146,000 K
Last Quarter Net Income, $ -10,230 K
60-Month Beta 0.67
% of Insider Shareholders 4.16%
% of Institutional Shareholders 95.75%

Growth:

1-Year Return 47.58%
3-Year Return 27.38%
5-Year Return 52.64%
5-Year Revenue Growth 153.49%
5-Year Earnings Growth 644.44%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.05 on 07/28/16
Latest Earnings Date 11/08/16
Earnings Per Share ttm -0.54
EPS Growth vs. Prev Qtr -125.00%
EPS Growth vs. Prev Year 50.00%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

CPHD Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -10.20%
Return-on-Assets % -4.61%
Profit Margin % -9.01%
Debt/Equity 43.18
Price/Sales 7.20
Price/Cash Flow N/A
Price/Book 10.19
Book Value/Share 5.18
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar